Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 ...
Researchers have found a significant link between screen time and diagnoses of attention deficit hyperactivity disorder.
"With LumosityRx, we're taking the core science and technology behind Lumosity and applying it to help people with ADHD, where attention is crucial to everyday life," said Dr. Bob Schafer, ...
Medical Device Network on MSN
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.
ADHD (attention-deficit/hyperactivity disorder) is stunningly expensive to both the economy and to the people who live with ...
In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD). In the United States, for example, government researchers last year ...
Attention deficit hyperactivity disorder is a condition in which it is difficult for a person to maintain attention, control ...
LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.
Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results